Cergentis
Yalelaan 62, 3584 CM, UTRECHT, Netherlands
- Scope lines
- 2
- RvA certificate
- 1
- Site in our directory
- 1
What this lab is accredited for
We found no published test standard numbers in this lab’s scope. The full scope as published is below.
Only this lab. Searches the method, matrix and range of each of the 2 scope lines.
RvA certificate L671 · 2 lines
| Line | Method | Matrix | Range |
|---|---|---|---|
| 1 | - | Cells isolated from bone marrow, spleen, liver or kidney; White blood cells isolated from fresh blood samples; Cultured T-Cells, ESCs and iPSCs; Cell lines (for example CHO, HELA, HEK293T); Yeast cells; Cells isolated from embryos or whole fish; VectorsShow page textExtracted from the scope document; tables may not line up. View scope for the original. Annex to declaration of accreditation (scope of accreditation)
Normative document: EN ISO/IEC 17025:2017
Registration number: L 671
of Cergentis B.V. trading as Solvias NL
Department Services
This annex is valid from: 23-10-2025 to 01-02-2030 Replaces annex dated: 09-10-2024
Location(s) where activities are performed under accreditation
Head Office
Yalelaan 62
3584 CM
Utrecht
The Netherlands
Dutch Accreditation Council RvA Page 1 of 2
This annex has been approved by the Board of the
Dutch Accreditation Council, on its behalf,
J.A.W.M. de Haas
Location Abbreviation/ location code
Yalelaan 62
3584 CM
Utrecht
The Netherlands
U
No. Material or product Type of activity1 Internal reference number Location
1. . Cells isolated from bone
marrow, spleen, liver or
kidney,
White blood cells isolated
from fresh blood samples,
Cultured T-Cells, ESCs
and iPSCs,
Cell lines (for example
CHO, HELA, HEK293T),
Yeast cells,
Cells isolated from
embryos or whole fish,
Vectors
Determination of the integrity of
the transgene vector sequence;
next generation sequencing
(NGS) and bio-informatic data
analysis
ASOP-0951, ASOP-0953, ASOP-
0941, ASOP-0937, ASOP-0950,
OSOP-0708, OSOP-0709
in house method
U
1 If there is a referral to a code starting with NAW, NAP, EA or IAF, this concerns a scheme mentioned on RvA-BR010-lijst.
If no date or version number is mentioned for a normative document, the accreditation concerns the most current version of the document or scheme. | - |
| 2 | - | Cells isolated from bone marrow, spleen, liver or kidney, White blood cells isolated from fresh blood samples, Cultured T-Cells, ESCs and iPSCs, Cell lines (for example CHO, HELA, HEK293T), Yeast cells, Cells isolated from embryos or whole fish; Isolated white blood cells and organoidsShow page textExtracted from the scope document; tables may not line up. View scope for the original. Annex to declaration of accreditation (scope of accreditation)
Normative document: EN ISO/IEC 17025:2017
Registration number: L 671
of Cergentis B.V. trading as Solvias NL
Department Services
This annex is valid from: 23-10-2025 to 01-02-2030 Replaces annex dated: 09-10-2024
Dutch Accreditation Council RvA Page 2 of 2
No. Material or product Type of activity1 Internal reference number Location
2. . Cells isolated from bone
marrow, spleen, liver or
kidney,
White blood cells isolated
from fresh blood samples,
Cultured T-Cells, ESCs
and iPSCs,
Cell lines (for example
CHO, HELA, HEK293T),
Yeast cells,
Cells isolated from
embryos or whole fish
Determination of the vector
integration site(s) and breakpoint
sequences between the vector
and genome; next generation
sequencing (NGS) and bio-
informatic data analysis
ASOP-0951, ASOP-0953, ASOP-
0941, ASOP-0937, ASOP-0950,
OSOP-0708, OSOP-0709
in house method
U
3. Determination of the presence of
structural variants surrounding
the vector integration site(s); next
generation sequencing (NGS)
and bio-informatic data analysis
ASOP-0951, ASOP-0953, ASOP-
0941, ASOP-0937, ASOP-0950,
OSOP-0708, OSOP-0709
in house method
U
4. Determination of transgene
components; next generation
sequencing (NGS), comparison
with reference libraries of
common vector elements and
bio-informatic data analysis
ASOP-0951, ASOP-0953, ASOP-
0941, ASOP-0937, ASOP-0950,
OSOP-0708, OSOP-0709
in house method
U
5. Determination of gene editing
events in endogenous loci; next
generation sequencing (NGS)
and bio-informatic data analysis
ASOP-0951, ASOP-0953, ASOP-
0941, ASOP-0937, ASOP-0950,
OSOP-0708, OSOP-0709
in house method
U
6. Isolated white blood cells
and organoids
Determination of integration
site(s) in heterogeneous cell
populations; next generation
sequencing (NGS) and bio-
informatic data analysis
ASOP-0951, ASOP-0953, ASOP-
0941, ASOP-0937, ASOP-0950,
OSOP-0708, OSOP-0709
in house method
U | - |
Ranges are reproduced from the accredited scope document as published, and only where we found that range printed in the document for the line. Otherwise the cell reads “See scope document”. An absent range means the register did not state one. Line numbers are ours, for cross-reference; they follow the order of the scope document.
Location
Accreditation data refreshed from the RvA register on .
This page mirrors a public register. For a purchasing, audit or regulatory decision, confirm against the RvA entry linked above.